Sources we rely on
| Topic | Primary sources | Used for |
|---|---|---|
| Sterile compounding | USP General Chapter <797> (2023 revision); state Board of Pharmacy rules | Immediate-use limits, beyond-use dates, inspection expectations |
| Compounding pharmacies | FD&C Act sections 503A and 503B; FDA outsourcing facility registry and guidance | Sourcing rules, office stock vs patient-specific |
| Drug information | FDA-approved prescribing information (package inserts), FDA safety communications | Doses, contraindications, interactions (e.g. biotin assay interference, ceftriaxone-calcium) |
| Infusion nursing | Infusion Nurses Society Standards of Practice | Vascular access, catheter selection, site care |
| Reimbursement | CMS Home Infusion Therapy benefit materials; AMA CPT; IRS Publication 502 | CPT 99601/99602, G0068–G0070, G0088–G0090, HSA/FSA rules |
| State law | State medical, nursing and pharmacy practice acts, board position statements and declaratory rulings | CPOM, delegation, GFE and IV hydration guidance |
| Sport | World Anti-Doping Code Prohibited List | IV infusion volume limits for athletes |
Review steps
- Draft against primary sourcesDose ranges, statutes and codes are taken from the source text, not secondary blogs.
- Clinical checkFormulations, rates, osmolarity math and contraindications are checked for internal consistency and conservative safety thresholds.
- Regulatory checkState summaries name the issuing board and the statute or guidance; where text is ambiguous or changing, the page says so.
- Price benchmarkingPrices are ranges from published menus and operator benchmarks, presented as planning estimates, never quotes.
- Language checkWellness uses are described as such; no page claims a drip treats or cures disease.
- Update triggersNew USP revisions, FDA actions, board statements or legislation trigger re-review of every affected page.
Independence and corrections
Pages do not carry paid placements. Network practices cannot edit clinical or regulatory content. If you find an error, write to clinical@ivconnection.com with the page and the source; verified corrections are made and the page’s review date updated.
Educational content. Clinical pages do not replace an evaluation by a licensed prescriber, and regulatory pages are not legal advice.